Inhalers Market: By Devices, By Type, By Application, By End User, and Region Forecast 2020-2031

download arrow download arrow Download Sample
settings arrow settings arrow email us

Inhalers Market Size, Share, Growth, Trends, and Global Industry Analysis: By Devices (Metered Dose Inhaler, Dry Powder Inhaler and Nebulizer), By Type (Preventive Inhaler, Reliever Inhaler and Long-acting Bronchodilators Inhaler), By Application (Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension and Cystic Fibrosis), By End User (Home Care and Hospitals & Clinics), and Region Forecast 2020-2031

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Inhalers market size was valued at US$ 18.4 billion in 2024 and is expected to reach US$ 63.6 billion by 2031, growing at a significant CAGR of 19.4% from 2025-2031. Due to an increase in occurrences of respiratory disorders, particularly the diagnosis and treatment of COVID-19, hospital and clinical visits increased considerably, resulting in an increase in demand for inhalers and nebulizers, propelling the market forward. Various collaborations, partnerships, and acquisitions between pharmaceutical companies and smart inhaler manufacturers have increased competition in the smart inhaler industry, and the rise in healthcare expenditure in such economies presents lucrative opportunities for the market; thus, is a great opportunity for key players to invest.

Although inhalers have proven to be very successful devices, the wide variety of devices available can make it difficult for physicians to determine which one is best for a certain patient. In the future years, the market will be driven by the rise in popularity of smart respiratory inhaler devices. Smart inhaler devices connect to a smartphone app, allowing users to keep track of dose reminders and prescription schedules.

Key Developments

  • In January 2021, Vector Capital announced the acquisition of Mood Media, the world's top in-store media solutions company dedicated to improving consumer satisfaction.
  • In July 2020, Novartis received the European Commission (EC) permission for Enerzair Breezhaler, which has the first digital companion (sensor and app) in the EU that can be prescribed alongside asthma medication.
  • In May 2020, Iconovo received CE mark approval for its capsule-based dry powder inhaler ICOcap for use in clinical trials.

summary download arrow Download Sample

Inhalers Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

4.3%

Largest Market

North-America

Fastest Growing Market

Europe

Inhalers Market Dynamics

The rising prevalence of COPD and asthma is a primary driver of market expansion. The number of people aged 65 and above in the United States is expected to nearly treble by 2050, with those aged 85 and up constituting the fastest-growing age group. Patients with asthma and COPD who live longer have more physical and cognitive co-morbidities, which impact their ability to use inhaler devices.

As the amount of ozone and particle matter in the air rises, the likelihood of developing asthma symptoms rises at an alarming rate. As a result, an increase in air pollution is predicted to directly contribute to a spike in asthma and COPD cases, propelling the market forward. However, high cost of the products is impelling the market growth.

Inhalers Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2024

US$ 18.4 billion

Market Size in 2031

US$ 63.6 billion

Market CAGR

4.3%

By Device Type

  • Metered Dose Inhaler
  • Dry Powder Inhaler
  • Nebulizer
    • Compressed
    • Ultrasonic
    • Mesh

By Type

  • Preventive Inhaler
  • Reliever Inhaler
  • Long-acting Bronchodilators Inhaler

By Application

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Cystic Fibrosis

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The inhalers market report provides granular level information about the market size, country market share, historic market (2020-2024) and forecast (2025-2031)
  • The report covers in-detail insights about the competitors overview, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global inhalers market size was valued at US$ 19,445.4 million in 2023 and is projected to grow at a CAGR of 4.3%.

Europe is the fastest-growing region for inhalers market

3M Company, Aradigm Corporation, AstraZeneca Plc., Boehringer Ingelheim GmbH, Cipla Inc., GlaxoSmithKline

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Inhalers Market Introduction 
2.1.Global Inhalers Market  - Taxonomy
2.2.Global Inhalers Market  - Definitions
2.2.1. By Machinery Type
2.2.2. By Type
2.2.3. By Application
2.2.4. By Region
3.Global Inhalers Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Inhalers Market Analysis, 2020 - 2024 and Forecast 2025 - 2031
4.1.  Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Inhalers Market  By Machinery Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
5.1. Metered Dose Inhaler
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Dry Powder Inhaler
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Nebulizer
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Inhalers Market  By Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
6.1. Preventive Inhaler
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Reliever Inhaler
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Long-acting Bronchodilators Inhaler
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Inhalers Market  By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
7.1. Asthma
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Chronic Obstructive Pulmonary Disease
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Pulmonary Arterial Hypertension
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Cystic Fibrosis
7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Inhalers Market  By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Inhalers Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
9.1. Machinery Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Metered Dose Inhaler
9.1.2.Dry Powder Inhaler
9.1.3.Nebulizer
9.2.  Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Preventive Inhaler
9.2.2.Reliever Inhaler
9.2.3.Long-acting Bronchodilators Inhaler
9.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Asthma
9.3.2.Chronic Obstructive Pulmonary Disease
9.3.3.Pulmonary Arterial Hypertension
9.3.4.Cystic Fibrosis
9.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Inhalers Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
10.1. Machinery Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Metered Dose Inhaler
10.1.2.Dry Powder Inhaler
10.1.3.Nebulizer
10.2.  Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Preventive Inhaler
10.2.2.Reliever Inhaler
10.2.3.Long-acting Bronchodilators Inhaler
10.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Asthma
10.3.2.Chronic Obstructive Pulmonary Disease
10.3.3.Pulmonary Arterial Hypertension
10.3.4.Cystic Fibrosis
10.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Inhalers Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
11.1. Machinery Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Metered Dose Inhaler
11.1.2.Dry Powder Inhaler
11.1.3.Nebulizer
11.2.  Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Preventive Inhaler
11.2.2.Reliever Inhaler
11.2.3.Long-acting Bronchodilators Inhaler
11.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Asthma
11.3.2.Chronic Obstructive Pulmonary Disease
11.3.3.Pulmonary Arterial Hypertension
11.3.4.Cystic Fibrosis
11.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Inhalers Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
12.1. Machinery Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Metered Dose Inhaler
12.1.2.Dry Powder Inhaler
12.1.3.Nebulizer
12.2.  Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Preventive Inhaler
12.2.2.Reliever Inhaler
12.2.3.Long-acting Bronchodilators Inhaler
12.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Asthma
12.3.2.Chronic Obstructive Pulmonary Disease
12.3.3.Pulmonary Arterial Hypertension
12.3.4.Cystic Fibrosis
12.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Inhalers Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
13.1. Machinery Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Metered Dose Inhaler
13.1.2.Dry Powder Inhaler
13.1.3.Nebulizer
13.2.  Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Preventive Inhaler
13.2.2.Reliever Inhaler
13.2.3.Long-acting Bronchodilators Inhaler
13.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Asthma
13.3.2.Chronic Obstructive Pulmonary Disease
13.3.3.Pulmonary Arterial Hypertension
13.3.4.Cystic Fibrosis
13.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.3M Company (USA)
14.2.2.Aradigm Corporation (California)
14.2.3.AstraZeneca Plc. (UK)
14.2.4.Boehringer Ingelheim GmbH (Germany)
14.2.5.Cipla Inc. (India)
14.2.6.GlaxoSmithKline (UK)
14.2.7.BESPAK (UK)
14.2.8.Beximo Pharmaceuticals Limited (Bangladesh)
14.2.9.Spyryx Biosciences, Inc. (North Carolina)
14.2.10.MidasCare Pharmaceuticals Pvt. Ltd. (India)
14.2.11.Omega Life Sciences Ltd. (Isreal)
14.2.12.Drive DeVilbiss Healthcare Ltd. (UK)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • 3M Company (USA)
  • Aradigm Corporation (California)
  • AstraZeneca Plc. (UK)
  • Boehringer Ingelheim GmbH (Germany)
  • Cipla Inc. (India)
  • GlaxoSmithKline (UK)
  • Novartis AG (Switzerland)
  • PULMATRIX, INC. (USA)
  • Teva Respiratory, LLC. (USA)
  • Mankind Corporation (Califonia)
  • BESPAK (UK)
  • Beximo Pharmaceuticals Limited (Bangladesh)
  • Spyryx Biosciences, Inc. (North Carolina)
  • MidasCare Pharmaceuticals Pvt. Ltd. (India)
  • Omega Life Sciences Ltd. (Isreal)
  • Drive DeVilbiss Healthcare Ltd. (UK)
  • Manta Devices LLC. (Cambridge)
  • Savara Inc. (USA)
  • OMRON Healthcare Europe B.V. (Europe)
  • Hovione LLC. (USA)
  • Koninklijke Philips N.V. (Netherlands)
  • Teijin Limited (Japan)
  • Vitalograph Ltd. (UK)

Related Industry Reports

Asthma Spacers Market

Long-Acting Injectables Market